DU KOMMER VEL TIL NASJONAL KONFERANSE HELSE 
MEDTEK & BIOTEK?

HOLMEN FJORDHOTEL DEN 29. SEPTEMBER.

Innovasjon Norges sektorgruppe Helse har gleden av å invitere til en spennende konferanse om medisinsk innovasjon og internasjonale muligheter. Tirsdag 29. september på Holmen Fjordhotell i Asker utenfor Oslo (www.holmenfjordhotell.no)

·         Key note speakers vil være:

Steven Burrill, CEO fra Burrill & Co i San Francisco – en verdenskjent opinionsleder innen life science som utgir sin årlige ”State of the Industry Report”

Ørn Stuge, Senior VP fra Medtronic Inc. i Sveits – norsk toppleder med lang erfaring fra internasjonal medtek industri

·         Konferansen vil belyse spesifikke norske utfordringer og muligheter i dagens marked med hensyn til innovasjon, kommersialisering og finansiering.

·         Eget seminar og workshop for unge norske medtek bedrifter med praktiske øvelser ledet av erfarne grundere og eksperter fra USA og Norge.

·         Unik mulighet for å diskutere hjelp til finansiering og forretningsutvikling i en-til-en møter med Innovasjon Norges sektorgruppe Helse 

·         En nettverksarena med sentrale representanter for norsk medtek og biotek industri, akademia, helsevesen, investorer og virkemiddelapparat.

Se vedlagte program i pdf-format nederst på siden.
For påmelding benytt påmeldingsskjmaet  som er tilgjengelig i den venstre grå kolonnen på denne siden. Her kan du også avtale indivuelt møte med Innovasjon Norge. For overnatting, ta kontakt med Holmen Fjordhotell, på 66 77 27 00 eller via www.holmenfjordhotell.no

GRATIS DELTAGELSE, MEN AV PRATISKE ÅRSAKER TRENGER VI DIN PÅMELDING INNEN MANDAG 21.SEPTEMBER.

På vegne av Innovasjon Norge helsesektor-team:

Ole Jørgen Marvik                                                  Sander J. Tufte
Satsingsansvarlig Helse                                        Stasjonssjef, IN Boston
+47 911 95 876                                                        +1 617 818 3900

For praktisk informasjon kontakte:

Marit S. Valseth                                                      
Project Manager, Health and Life Sciences   
+47 909 66 998    

                                      

 

 

                     

 

 

The program will evolve around different strategies to establish a market presence in the US and a required knowledge in order to be successful in this market.

The faculty will consist of seasoned industry experts, entrepreneus and investors. Members of the Innovation Norway team will assist and arrange indiviual meetings, in addition to organize plenary workshops/problem-solving clinics.

Medtech Seminar

Before we put together a program for a Medtech Business Primer and Seminar we would very much like to know YOUR needs with regards to learning and doing Medtech business in the US. Please take the time to fill out this short survey.

Company nameMy business is in the following medtech segment * Devices/technolgy for diagnosis Devices/technololgy for therapeutic intervention Medical implants Medical devices ex vivo Bioinformatics OtherContact personContact person's e-mailPhoneWhen is a good time for your company to attend a medtech seminar? * The first half of May is a good time June is better July is better August is better September is better

What format would you prefer for the educational session of the seminar?

Lectures on the following topics;Meeting industry experts/consultants *12345Meeting other companies/potential partners *12345Site visit to a successful medtech company *12345Visiting an academic institution with a program on entrepreneurship *12345Boston, Minneapolis and San Francisco are all home to some of the biggest medtech clusters in the world. Where would you like to attend a medTech seminar? * 1.Boston, Massachusetts 2.San Francisco, California 3.Minneapolis, Minnesota 4.Orange County, California 5.In Norway with experts invited from the US. 6.My company does not need to attend a seminar at this momentA combination of alternative 1,2,3 or 4

GENERAL SURVEY - MARKET AND ASSISTANCE PREFERENCES, 1=LOW, 5=HIGH

My focus on the US Market (1=low, 5=high) *12345My focus on the European market *12345My focus on the Japanese market *12345My focus on the Middle East market *12345My focus on the Indian market *12345My focus on the Chinese market *12345My focus on other markets, type your preferenceNeed to identify and establish contact with business partners *12345Need for assistance with market and competition assessment *12345Need to increase visibility towards investors *12345Need for assistance with reimbursment models *12345Need for advice from clinical opinion leaders *12345Need for assistance with IPR and patent applications *12345Need for assistance with regulatory(FDA) applications. *12345Need for assistance with incorporation in the preferred market *12345Need for local recruitment *12345Need for education on local business culture *12345

The target group for this medtech workshop is start-ups and SME's who intend to enter the US market within the next 1-3 years with a device for diagnosis, intervention or ex-vivo applications. 

The Annual Anglonordic Biotech Conference

The Anglo-Nordic region continues to be one of the fastest growing biotech regions in the world and the sixth AngloNordic Biotech Conference, which took place in London on the 23. of April this year confirmed the success of this Northern European community. 

Through the co-organisers (UK Trade & Investment, Swedish Trade Council, Innovation Norway and the Danish Trade Council) this is the only conference where the national industry facilitators co-operate with their unique local knowledge of their respective companies.  In addition Atlas Venture LLP (international venture capital firm), also a co-organiser, support the conference with in-depth knowledge and a global network within the venture capital industry. 

The conference consisted  of four areas and one of the areas is Atlas Venture’s Investment Room. Atlas Venture’s Investment Room is already considered by many as one of the best biotech investment forums in Europe.

This conference is by invitation only and the select audience is restricted to drug discovery-, biopharmaceutical and venture capital firms.

The next AngloNordic Biotech conference will take place in London in May 2010. 

Location: London (UK)

Contact: Mattias Johansson

Email: mattias@anglonordicbiotech.com

Phone: +46-733-371182

Fax: +46-431-89420

Website: http://www.anglonordicbiotech.com/